- Anti-oxidant/anti-inflamatory nanoparticles to protect the brain from excess electrophysiology and to mitigate damage post-crisis
- Characterization of the didys552 zebrafish mutant line (mutation in snc1lab gene) and set up of an efficacy drug screening assay using reference compounds
- Cell Therapy with GABAergic interneuron precursors for Early Infantil Epileptic Encephalopathies (S. Dravet, S. West y S. Stxbp1)
- Creation of a therapeutic drug monitoring (TDM) unit for the optimization of the Dravet syndrome pharmacological therapy
- Design, synthesis and pharmacological evaluation of new neuroprotective agents oriented to the tratment of Dravet syndrome
- Efecto de campos magnéticos estáticos de intensidad moderada en modelos de epilepsia y síndrome de Dravet
- The effect of beta-caryophyllene treatment in a murine model of Dravet syndrome
- The endocannabinoid system study in Dravet syndrome
- Intrinsic neuronal excitability and spontaneous 1 activity underlie cortical abnormalities upon Nr2f1/COUP-TFI deficiency
- Investigating Epilepsy by Super-resolution Imaging of Synapses and the Extracellular Space in Live Brain Tissue
- Precision Medicine in Dravet Syndrome
- Reactive Neurogenesis and Gliogenesis in a Dravet Syndrome Mouse Model
(Laboratory of Neuronal Excitability)
(Laboratory of Neuronal Excitability)
Duration: 2019-2020 Construction of STED microscope 2020-2021 Utilization of the STED microscope in settings of experimental epilepsy and Dravet’s syndrome.
Proyect cost: 200.000 Euros.
Scientific groups: We seek to adopt and develop novel STED imaging methods that allow visualization of brain tissue at unprecedented nanoscale resolution in live brain slices. This will allow us to investigate new aspects of experimental epilepsy and Dravet’s Syndrome.
The first step of this work is the construction of a highly advanced new type of microscope (STED microscope) at our facilities on the Campus Area of the UPV/EHU in Leioa. Only a handful of similar microscopes exist worldwide, and they have not yet been applied to study Dravet’s Syndrome.
We expect that our efforts will provide much needed new knowledge on Dravet’s Syndrome and related disorders characterized by hyperexcitatory signaling.
60.000 Euros.
Sponsors
MINECO
EHU/UPV